With the analysis with clinical data from the TCGA and CPTAC database, we found that hnRNPA2B1 was significantly upregulated in both lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) patients at mRNA levels (Figure 6A). The gene discussed is HNRNPA2B1; the disease is lung adenocarcinoma.